Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study Using Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

NCT02873416 is registered in ClinicalTrials.gov with Ningbo Cancer Hospital as lead sponsor.

NCT NCT02873416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02873416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study Using Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer
Lead sponsor
Ningbo Cancer Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2016
Completion date
August 31, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced lung cancer, chemotherapy, precision cell immunotherapy